New imaging system and artificial intelligence algorithm accurately identify brain tumors

byNYU Langone HealthStimulated Raman histologic images of diffuse astrocytoma (left) and meningioma (right). Credit: Daniel Orringer, NYU Langone HealthA novel method of combining advanced optic

Updated on: December 22,2023

New imaging system and artificial intelligence algorithm accurately identify brain tumors

byNYU Langone HealthStimulated Raman histologic images of diffuse astrocytoma (left) and meningioma (right). Credit: Daniel Orringer, NYU Langone HealthA novel method of combining advanced optic

Updated on:December 22,2023

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

Updated on: July 08,2024

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

Updated on:July 08,2024

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on: March 22,2024

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Updated on:March 22,2024

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th

Updated on: March 22,2024

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th

Updated on:March 22,2024

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici

Updated on: December 28,2023

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici

Updated on:December 28,2023

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on: July 17,2024

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on:July 17,2024

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on: December 20,2023

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on:December 20,2023

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on: July 17,2024

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on:July 17,2024

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1

Updated on: December 20,2023

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1

Updated on:December 20,2023

Cancer study may accidentally help researchers create usable blood stem cells

by Garth Sundem,CU Anschutz Medical CampusBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA massive research effort over more than a quarter

Updated on: December 22,2023

Cancer study may accidentally help researchers create usable blood stem cells

by Garth Sundem,CU Anschutz Medical CampusBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaA massive research effort over more than a quarter

Updated on:December 22,2023

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on: January 08,2024

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on:January 08,2024